Cytonome Inc. develops, manufactures, and markets clinical grade optical cell sorting technology. Cytonome's Gigasort system is the only clinical grade, cGMP compliant optical cell sorter built around a closed, sterile and disposable cartridge to guarantee operator safety and sample isolation. Cytonome's revolutionary technology can be used for the precise and safe selection of discrete cell subpopulations. Gigasort™ technology has been designed for use in cGMP cell production environments where investigators wish to transition pre-clinical protocols to clinical production and develop new cell therapy inventions. The Gigasort™ cell sorter will enable a broad array of cell and gene therapies, including new treatments for cancer, autoimmune disease and regenerative medicine applications.
At Cytonome, we strive to provide our customers with the finest science, customer service and innovation and welcome collaborative inquiries. Cytonome was founded in 2002 and is headquartered in Boston, Massachusetts.